Author

Meng Jiao

Duke Medical CenterORCID 0000-0001-6698-3482Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:mechanistic / dynamical model· 1 Organism:mouse· 1

Frequent Co-Authors

Chuan‐Yuan LiiD· 1 shared Dong PaniD· 1 shared Fang LiiD· 1 shared Jonathan KimiD· 1 shared Mengjie HuiD· 1 shared Xinjian LiuiD· 1 shared Xuhui Bao· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chuan‐Yuan LiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintNov 28, 2023

VHL loss enables immune checkpoint blockade therapy by boosting type I interferon response.

Meng Jiao, Xuhui Bao, Mengjie Hu…·Chuan‐Yuan Li

This study shows that VHL loss in ccRCC enhances anti-PD-1 therapy efficacy by increasing type I interferon response through HIF1/HIF2-mediated mtDNA leakage.

2 citations

mouseexperimental assay

𝕏 PostBluesky